Globus Medical (GMED) Misses Q1 EPS by 5c, Confirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports First Quarter 2019 Results
May 2, 2019 4:18 PM EDTAUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019.
Worldwide sales were $182.9 million, an increase of 4.9% as reportedFirst quarter net income was $33.2 million, a decrease of 16.0%Diluted earnings per share (EPS) was $0.33 and non-GAAP diluted EPS was $0.36Non-GAAP diluted EPS decreased 13.4% compared to first quarter of 2018Non-GAAP adjusted EBITDA was 31.1% of salesOur first quarter results demonstrate continued strong momentum in... More
